February 11, 2022
Feature Articles
31
1/2
Six best practices and three key mistakes to avoid in new technology space.
February 11, 2022
Feature Articles
31
1/2
Phase I/II study in cancer patients showcases eClinical effectiveness.
February 11, 2022
Feature Articles
31
1/2
With large shift to decentralized strategies, industry roles appear set for change.
February 11, 2022
View from Brussels
31
1/2
2022 EU initiative provides hope for improvement of trial regulations.
February 11, 2022
From the Editor
31
1/2
Looking to US Medicare/Medicaid to increase patient participation.
February 11, 2022
31
1/2
Michael J. Hennessy, Sr., was the beloved chairman and CEO of MJH Life Sciences, parent company of Applied Clinical Trials.
February 11, 2022
Issue PDF
31
1/2
Click the title above for a link to open the Applied Clinical Trials January/February 2022 issue in an interactive PDF format.
January 26, 2022
View from Washington
31
1/2
Uncertainty over experimental medicines calls for review of AA process.
January 11, 2022
Q&A
31
1/2
Dr. Harish Dave, CEO of Singapore-based AUM Biosciences, discusses evolving strategies for Asian biopharmaceutical enterprises.
January 04, 2022
A Closing Thought
31
1/2
The need for specific capabilities to suit DCT business models is creating new challenges in team building, training, and development.
January 03, 2022
Feature Articles
31
1/2
New requirements must be put in place to ensure data quality and integrity.
December 16, 2021
Feature Articles
31
1/2
Optimizing feasibility through increased data collection.